EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and molecular landscape of surgically resected early onset pancreatic cancer

Stephan B Dreyer iD, Adam Bryce, Fieke Froeling, Shannon Jackson, Leonor Santana, Euan J Dickson, Maria Coats, Colin McKay, David Holroyd, Andrew V Biankin, Nigel B Jamieson iD, David K Chang

British Journal of Surgery · 07.05.2026 · 113 (5)

DOI: 10.1093/bjs/znag032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 07.05.2026. Verfasst von Stephan B Dreyer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Pancreatectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Health & Medical Research Council of Australia, Cancer Council NSW, Cancer Institute NSW.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The increase in incidence of early-onset pancreatic cancer (EOPC) is of concern and poorly understood. The aim of this study was to investigate the clinical outcomes of surgically resected patients with EOPC and the potential molecular heterogeneity between EOPC and late age-onset disease.

Methods

A retrospective cohort study was conducted, with clinical, pathological, and survival outcome data obtained from two large independent prospective cohorts curated by the Australian Pancreatic Genome Initiative (APGI) and the West of Scotland Pancreatic Unit (Glasgow Royal Infirmary) between 1997 and 2022. Patients were categorized into two age groups (<50 and ≥50 years) at time of diagnosis. Clinicopathological features and survival outcomes, in addition to gene expression and tumour microenvironment data, were compared between groups.

Results

In total, 851 patients were identified, of whom 68 (8%) were aged <50 years. EOPC was associated with significantly earlier recurrence after surgery (median disease-free survival (DFS) 10.9 versus 14.2 months; P = 0.011) and there was no statistically significant difference in disease-specific survival (median 19.9 versus 23.8 months; P = 0.117). There were no differences in validated clinicopathological variables to account for the shorter DFS in the EOPC group. Despite an increased proportion of patients with EOPC receiving adjuvant chemotherapy (P = 0.032), DFS was significantly worse (DFS 12.6 versus 16.0 months; P = 0.022). EOPC demonstrated enrichment of genes associated with more aggressive molecular pathology and the squamous (basal-like) molecular subtype of pancreatic ductal adenocarcinoma, including S100A2 (P < 0.001) and TP63 (P = 0.044), and down-regulation of GATA6 (P = 0.016).

Conclusion

EOPC is associated with a shorter time to recurrence and more aggressive, adverse molecular pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsPancreatectomyHumansMiddle AgedFemaleRetrospective StudiesAge of OnsetMaleAgedAdultNeoplasm Recurrence, LocalTumor MicroenvironmentDisease-Free Survival

Autor:innen und Institutionen

  • Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK.
  • Department of HPB/Transplant Surgery, Royal Infirmary of Edinburgh, Edinburgh, UK.
  • Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK.

ORCID-Profile: Stephan B Dreyer, Nigel B Jamieson

Förderung

  • The National Health & Medical Research Council of Australia
  • Cancer Council NSW
  • Cancer Institute NSW
  • Royal Australasian College of Surgeons
  • St Vincent's Clinic Foundation
  • The Australian Pancreatic Cancer Foundation
  • St Vincent’s Clinic Foundation

Zitieren

APA

Dreyer, S. B., Bryce, A., Froeling, F., Jackson, S., Santana, L., Dickson, E. J., Coats, M., McKay, C., Holroyd, D., Biankin, A. V., Jamieson, N. B., & Chang, D. K. (2026). Clinical and molecular landscape of surgically resected early onset pancreatic cancer. British Journal of Surgery, 113(5). https://doi.org/10.1093/bjs/znag032

Vancouver

Dreyer SB, Bryce A, Froeling F, Jackson S, Santana L, Dickson EJ, et al. Clinical and molecular landscape of surgically resected early onset pancreatic cancer. British Journal of Surgery. 2026;113(5). doi:10.1093/bjs/znag032

BibTeX
@article{Dreyer2026,
  author = {Dreyer, Stephan B and Bryce, Adam and Froeling, Fieke and Jackson, Shannon and Santana, Leonor and Dickson, Euan J and Coats, Maria and McKay, Colin and Holroyd, David and Biankin, Andrew V and Jamieson, Nigel B and Chang, David K},
  title = {Clinical and molecular landscape of surgically resected early onset pancreatic cancer},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {5},
  doi = {10.1093/bjs/znag032}
}
Kostenlos starten →